Aardvark Therapeutics, Inc. Common Stock
General ticker "AARD" information:
- Sector: Health Care
- Industry: Biotechnology
- Capitalization: $204.0M (TTM average)
Aardvark Therapeutics, Inc. Common Stock follows the US Stock Market performance with the rate: 31.2%.
Estimated limits based on current volatility of 5.5%: low 13.98$, high 15.60$
Factors to consider:
- Total employees count: 10000 as of 2024
Short-term AARD quotes
Long-term AARD plot
Financial data
| YTD | 2022-12-31 | 2023-12-31 | 2024-12-31 |
|---|---|---|---|
| Operating Revenue | $0.00MM | $0.00MM | $0.00MM |
| Operating Expenses | $11.36MM | $7.42MM | $22.79MM |
| Operating Income | $-11.36MM | $-7.42MM | $-22.79MM |
| Non-Operating Income | $-2.20MM | $0.21MM | $2.20MM |
| R&D Expense | $7.17MM | $4.48MM | $17.36MM |
| Income(Loss) | $-13.56MM | $-7.21MM | $-20.59MM |
| Profit(Loss)* | $-13.56MM | $-7.21MM | $-20.59MM |
| Stockholders Equity | $-27.92MM | $-34.80MM | $-54.64MM |
| Assets | $16.76MM | $10.54MM | $77.51MM |
| Operating Cash Flow | $-10.54MM | $-5.82MM | $-18.09MM |
| Capital expenditure | $0.00MM | $0.00MM | $0.11MM |
| Investing Cash Flow | $-1.00MM | $0.00MM | $-12.00MM |
| Financing Cash Flow | $0.23MM | $0.00MM | $81.99MM |
| Earnings Per Share** | $-1.39 | $-0.56 | $-1.59 |
* Profit(Loss) attributable to entity.
** EPS are Split Adjusted, recent splits may be reflected with a delay.